Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
The pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission (FTC) released its second interim staff report on prescription drug middlemen.
The term Web Client Runtime Security (WCRS) was coined by the authors to highlight the security or possible malicious behavior of the code executed in users' browsers during their web interactions.
Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
The FTC analyzed data for 51 specialty generic drugs dispensed from 2017-2022 for patients with commercial insurance or Medicare Part D plans managed by CVS Caremark, Express Scripts and OptumRx.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback